Acies Pharmaceutical Private Limited, a active private limited company, was established on 19 April 2019 in Dehradun, Uttarakhand, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74999UR2019PTC009735. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Bhasker Dabral (Director), Sujata Dabral (Director). It holds ₹10.39 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at First Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, 248001.
U74999UR2019PTC009735
009735
19 April 2019
₹0.10 M
₹0.10 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Acies Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhasker Dabral | Director | 19 Apr 2019 | Current |
| Sujata Dabral | Director | 19 Apr 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Acies Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.63% increase. The company also saw a substantial improvement in profitability, with a 106.9% increase in profit. The company's net worth Soared by an impressive increase of 90.89%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Acies Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹103,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹5.39 Cr | Open |
| 24 Jan 2024 | Axis Bank Limited | ₹3.60 Cr | Open |
| 29 Jan 2022 | Others | ₹1.40 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Acies Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Acies Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acies Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 53.90 M with Charge ID 101100014 was registered on 27 May 2025. was recorded as a recent event.
The activity Acies Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Acies Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was documented.
A charge with Axis Bank Limited amounted to Rs. 36.00 M with Charge ID 100880730 was registered on 24 Jan 2024. was recorded as a recent event.
The activity A charge with Others of Rs. 14.00 M registered on 29 Jan 2022 with Charge ID 100540219 was modified on 25 May 2023. was completed.
Progress on A charge with Others amounted to Rs. 14.00 M with Charge ID 100540219 was registered on 29 Jan 2022. was documented.
The CIN of Acies Pharmaceutical Private Limited is U74999UR2019PTC009735.
Acies Pharmaceutical Private Limited is headquartered at First Floor 74/1 Nari Shilip Marg, Dehradun, Uttarakhand, 248001.
Acies Pharmaceutical Private Limited was incorporated on 19 April 2019.
The current directors of Acies Pharmaceutical Private Limited are
The primary industry of Acies Pharmaceutical Private Limited is Trade.
Acies Pharmaceutical Private Limited is unlisted.
The authorized capital of Acies Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX